Home > Products > CD19 & CD47
> Recombinant Anti-CD19 x Anti-CD47 Bispecific Antibody (CrossMab)
Recombinant Anti-CD19 x Anti-CD47 Bispecific Antibody (CrossMab) (CAT#: CROSSAB-042)
Recombinant Anti-CD19 x Anti-CD47 Bispecific Antibody (CrossMab) is designed to be expressed as four chains with knobs-into-holes mutations and domain crossover. After one or multi-steps purification, high-purity antibody can be obtained. This BsAb can retarget macrophages to tumor cells. It is designed for the research of B cell lymphoma; Follicular lymphoma; Burkitt lymphoma; Leukemia therapy.
There are currently no customer reviews or questions for Recombinant Anti-CD19 x Anti-CD47 Bispecific Antibody (CrossMab) (CROSSAB-042). Click the button below to contact us or submit your feedback about this product.